Evaluation of early cardiac dysfunction in patients with systemic lupus erythematosus with or without anticardiolipin antibodies

被引:13
作者
Barutcu, A. [1 ]
Aksu, F. [2 ]
Ozcelik, F. [3 ]
Barutcu, C. A. E. [4 ]
Umit, G. E. [4 ]
Pamuk, O. N. [5 ]
Altun, A. [6 ]
机构
[1] Canakkale Onsekiz Mart Univ, Fac Med, Dept Cardiol, Canakkale, Turkey
[2] Istanbul Medeniyet Univ, Cardiol, Goztepe Training & Res Hosp, TR-34730 Istanbul, Turkey
[3] Trakya Univ, Dept Cardiol, Fac Med, Edirne, Turkey
[4] Trakya Univ, Dept Internal Med, Fac Med, Edirne, Turkey
[5] Trakya Univ, Fac Meicine, Deprtmet Rheumatol, Edirne, Turkey
[6] Baskent Univ, Istanbul Hosp, Dept Cardiol, Fac Med, Istanbul, Turkey
关键词
Anticardiolipin antibody; tissue Doppler; diastolic dysfunction; systemic lupus erythematosus; cardiovascular disease; VENTRICULAR DIASTOLIC FUNCTION; CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; RISK-FACTORS; ACCELERATED ATHEROSCLEROSIS; ANTIPHOSPHOLIPID ANTIBODIES; TISSUE DOPPLER; ECHOCARDIOGRAPHY; ABNORMALITIES; ASSOCIATION;
D O I
10.1177/0961203315570164
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to use transthoracic Doppler echocardiographic (TTE) imaging methods to identify cardiac dysfunction, an indicator of subclinical atherosclerosis in asymptomatic systemic lupus erythematosus (SLE) patients in terms of cardiac effects. This study involved 80 patients: a study group (n=50) and control group (n = 30). They were categorized into four subgroups: anticardiolipin antibodies (aCL) (+) (n = 14) and aCL (-) (n = 36); systemic lupus erythematosus disease activity index (SLEDAI) >= 6 (n = 15) and SLEDAI < 6 (n = 35); disease period >= 5 years (n = 21) and disease period < 5 years (n = 29); major organ involvement (+) (n = 19), major organ involvement (-) (n = 31). The ratio of mitral peak velocity of early filling to early diastolic mitral annular velocity (E/E') for the study group was found to be higher than the control (p < 0.01). Systolic septal motion velocity (Ssm) was lower in the study group compared with the control (p < 0.01). Left atrium (LA) dimension was greater in the study group than the control (p < 0.01). Ssm was found to be lower in the aCL (+) patients compared with the control and aCL (-) groups (p < 0.01, p < 0.05, respectively). LA dimension was greater in the aCL (+) and (-) groups compared with the control, (p < 0.01, p < 0.05, respectively) and aCL groups compared with each other (p < 0.05). The E/E' ratio for the aCL (+) and (-) groups was found to be greater than the control (p < 0.05). In the study, both the Ssm and the late diastolic septal velocity (sA') was found to be lower in the SLEDAI >= 6 group compared with SLEDAI < 6 group, (p < 0.001, p < 0.05, respectively). LA dimension was statistically greater in the SLEDAI >= 6 group compared with the SLEDAI < 6 group (p < 0.001). E' and early diastolic septal velocity (sE') were statistically lower in the disease period > 5 years group compared with the disease period < 5 years group (p < 0.01, p < 0.05, respectively). Carrying out regular scans with TTE image of SLE patients is important in order to identify early cardiac involvement during monitoring and treatment. Identifying early cardiac involvement in SLE may lead to a reduction in mortality and morbidity rates.
引用
收藏
页码:1019 / 1028
页数:10
相关论文
共 47 条
  • [1] Role of tissue Doppler and strain echocardiography in current clinical practice
    Abraham, Theodore P.
    Dimaano, Veronica L.
    Liang, Hsin-Yueh
    [J]. CIRCULATION, 2007, 116 (22) : 2597 - 2609
  • [2] Abusamieh Mohammed, 2004, Cardiol Rev, V12, P267, DOI 10.1097/01.crd.0000124843.85660.ed
  • [3] Premature coronary-artery atherosclerosis in systemic lupus erythematosus
    Asanuma, Y
    Oeser, A
    Shintani, AK
    Turner, E
    Olsen, N
    Fazio, S
    Linton, MF
    Raggi, P
    Stein, CM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (25) : 2407 - 2415
  • [4] Mortality in systemic lupus erythematosus
    Bernatsky, S.
    Boivin, J. -F.
    Joseph, L.
    Manzi, S.
    Ginzler, E.
    Gladman, D. D.
    Urowitz, M.
    Fortin, P. R.
    Petri, M.
    Barr, S.
    Gordon, C.
    Bae, S. -C.
    Isenberg, D.
    Zoma, A.
    Aranow, C.
    Dooley, M. -A.
    Nived, O.
    Sturfelt, G.
    Steinsson, K.
    Alarcon, G.
    Senecal, J. -L.
    Zummer, M.
    Hanly, J.
    Ensworth, S.
    Pope, J.
    Edworthy, S.
    Rahman, A.
    Sibley, J.
    El-Gabalawy, H.
    McCarthy, T.
    Pierre, Y. St.
    Clarke, A.
    Ramsey-Goldman, R.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (08): : 2550 - 2557
  • [5] Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus
    Bessant, R
    Hingorani, A
    Patel, L
    MacGregor, A
    Isenberg, DA
    Rahman, A
    [J]. RHEUMATOLOGY, 2004, 43 (07) : 924 - 929
  • [6] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
    BOMBARDIER, C
    GLADMAN, DD
    UROWITZ, MB
    CARON, D
    CHANG, CH
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (06): : 630 - 640
  • [7] Bruce IN, 2000, J RHEUMATOL, V27, P2372
  • [8] Myocardial Left Ventricular Dysfunction in Patients with Systemic Lupus Erythematosus: New Insights from Tissue Doppler and Strain Imaging
    Buss, Sebastian J.
    Wolf, David
    Korosoglou, Grigorios
    Max, Regina
    Weiss, Celine S.
    Fischer, Christian
    Schellberg, Dieter
    Zugck, Christian
    Kuecherer, Helmut F.
    Lorenz, Hanns-Martin
    Katus, Hugo A.
    Hardt, Stefan E.
    Hansen, Alexander
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (01) : 79 - 86
  • [9] CARDIAC INVOLVEMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS DETECTED BY ECHOCARDIOGRAPHY
    CROZIER, IG
    LI, E
    MILNE, MJ
    NICHOLLS, MG
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (16) : 1145 - 1148
  • [10] CUJEC B, 1991, CAN J CARDIOL, V7, P343